Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KN motif and ankyrin repeat domain-containing protein 4 (KANK4) is a large, highly conserved protein of the KANK family, featuring an N-terminal KN motif, a coiled-coil domain, and C-terminal ankyrin repeats. KANK4 is particularly expressed in endothelial cells of arteries and arterioles, and its expression is upregulated under conditions of increased shear stress or tissue ischemia. KANK4 orchestrates arteriogenesis by physically linking VEGFR2 to the cytoskeletal protein TALIN-1, thereby augmenting VEGFR2 activation, downstream AKT signaling, and endothelial cell proliferation. This mechanistic action highlights KANK4 as a novel and promising therapeutic target for the treatment of arterial occlusive diseases. Beyond vascular biology, KANK4 also influences cell motility and actin cytoskeleton organization, and its upregulation in myofibroblasts is associated with pathological tissue remodeling, such as keloid formation
For experimental KANK4 modulation: Enhancement of VEGFR2 signaling cascade leading to increased AKT phosphorylation, endothelial cell proliferation, and vessel enlargement in model organisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KN motif and ankyrin repeat domain-containing protein 4 (KANK4).